GRCE

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Grace Therapeutics, Inc.

NASDAQ | GRCE

3.18

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$48.71M

Market Cap

-

P/E Ratio

-0.53

EPS

$4.97

52 Week High

$1.75

52 Week Low

HEALTHCARE

Sector

GRCE Chart

Recent Chart
Price Action

GRCE Technicals

Tags:

GRCE Earnings

Yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$7K
Total Revenue $0
Cost Of Revenue $7K
Costof Goods And Services Sold $7K
Operating Income -$17M
Selling General And Administrative $7.2M
Research And Development $9.5M
Operating Expenses $17M
Investment Income Net -
Net Interest Income $711K
Interest Income $711K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7K
Income Before Tax -$13M
Income Tax Expense -$3.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$9.6M
Comprehensive Income Net Of Tax -
Ebit -$17M
Ebitda -$17M
Net Income -$9.6M

Revenue & Profitability

Earnings Performance

GRCE Financials

yearly Balance Sheet (As of Mar 31, 2025)

Field Value (USD)
Total Assets $72M
Total Current Assets $23M
Cash And Cash Equivalents At Carrying Value $22M
Cash And Short Term Investments $22M
Inventory -
Current Net Receivables $126K
Total Non Current Assets $49M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $41M
Intangible Assets Excluding Goodwill $41M
Goodwill $8.1M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $453K
Other Non Current Assets -
Total Liabilities $5.4M
Total Current Liabilities $1.9M
Current Accounts Payable $601K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $3.5M
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1.3M
Other Non Current Liabilities -
Total Shareholder Equity $67M
Treasury Stock -
Retained Earnings -$221M
Common Stock $1K
Common Stock Shares Outstanding $12M

yearly Cash Flow (As of Mar 31, 2025)

Field Value (USD)
Operating Cashflow -$15M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $7K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.6M

yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$7K
Total Revenue $0
Cost Of Revenue $7K
Costof Goods And Services Sold $7K
Operating Income -$17M
Selling General And Administrative $7.2M
Research And Development $9.5M
Operating Expenses $17M
Investment Income Net -
Net Interest Income $711K
Interest Income $711K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7K
Income Before Tax -$13M
Income Tax Expense -$3.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$9.6M
Comprehensive Income Net Of Tax -
Ebit -$17M
Ebitda -$17M
Net Income -$9.6M

GRCE News

GRCE Profile

Grace Therapeutics, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Grace Therapeutics, Inc., based in Princeton, New Jersey, is an innovative pharmaceutical company committed to pioneering therapies for rare and orphan diseases. Leveraging cutting-edge research techniques and extensive clinical knowledge, Grace seeks to fulfill significant unmet medical needs both in Canada and globally. With a strong portfolio of specialized products in its pipeline, the company aims to improve patient outcomes and establish itself as a key player in the rare disease therapeutics market, reinforcing its position as a leader in this critical area of healthcare.

LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
INHD
-0.99%
$0.22
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
BURU
+9.84%
$0.24
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
ADTX
+21.01%
$3.80
DEFT
+9.35%
$1.52
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CAN
+0.75%
$0.92
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
NGD
+6.50%
$8.35
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.76%
$17.28
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.30%
$2.44
VHAI
-25.00%
$0.00
NVO
+1.31%
$49.35
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
BTE
+1.89%
$3.22
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
INHD
-0.99%
$0.22
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
BURU
+9.84%
$0.24
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
ADTX
+21.01%
$3.80
DEFT
+9.35%
$1.52
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CAN
+0.75%
$0.92
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
NGD
+6.50%
$8.35
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.76%
$17.28
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.30%
$2.44
VHAI
-25.00%
$0.00
NVO
+1.31%
$49.35
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
BTE
+1.89%
$3.22
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.